Here's the live share price of NGL Fine - Chem along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| NGL Fine - Chem | 5.02 | 10.91 | 28.86 | 54.49 | 178.10 | 16.09 | 0.67 |
| Sun Pharmaceutical Industries | -2.03 | 2.42 | 6.25 | 14.34 | 21.92 | 18.89 | 19.84 |
| Divi's Laboratories | 2.38 | 21.83 | 23.10 | 34.86 | 34.50 | 28.25 | 10.95 |
| Torrent Pharmaceuticals | -2.96 | 2.01 | 13.61 | 23.94 | 37.68 | 34.14 | 26.36 |
| Cipla | -0.06 | 1.35 | 8.01 | 9.65 | -1.30 | 6.36 | 9.89 |
| Zydus Lifesciences | -1.00 | -3.27 | 18.63 | 20.81 | 17.97 | 19.40 | 13.74 |
| Lupin | -2.23 | -5.22 | -4.06 | 7.32 | 21.26 | 29.71 | 15.79 |
| Mankind Pharma | -1.25 | -3.65 | 2.68 | 17.10 | -4.05 | 10.60 | 11.36 |
| Laurus Labs | 2.14 | 25.61 | 53.76 | 88.11 | 121.31 | 66.72 | 21.42 |
| Dr. Reddy's Laboratories | 2.13 | -13.43 | -10.32 | -8.07 | -2.39 | 1.33 | 4.01 |
| Aurobindo Pharma | 5.17 | 4.93 | 12.34 | 38.27 | 55.33 | 24.16 | 13.36 |
| Biocon | 1.02 | 5.68 | 12.39 | 15.00 | 17.94 | 18.08 | 2.38 |
| Alkem Laboratories | -1.90 | -0.38 | 0.94 | -1.80 | 15.69 | 10.94 | 9.88 |
| Glenmark Pharmaceuticals | 2.40 | 1.04 | -3.54 | 15.79 | 10.84 | 41.01 | 31.10 |
| Abbott India | 0.06 | 4.08 | 4.16 | 1.18 | -15.15 | 5.10 | 9.68 |
| Anthem Biosciences | 3.87 | 9.52 | 7.85 | 24.79 | 11.94 | 4.78 | 2.84 |
| GlaxoSmithKline Pharmaceuticals | -2.01 | 8.20 | 4.88 | 3.54 | -2.95 | 22.96 | 9.76 |
| Ipca Laboratories | -0.70 | -3.23 | 11.36 | 19.51 | 24.74 | 23.09 | 8.61 |
| Ajanta Pharma | 0.29 | 4.90 | 12.99 | 21.74 | 33.05 | 25.85 | 17.93 |
| Gland Pharma | 4.42 | 2.51 | 39.75 | 38.72 | 33.61 | 24.85 | -8.35 |
Source: Dion Global
Over the last one year, NGL Fine - Chem has gained 178.10% compared to peers like Sun Pharmaceutical Industries (21.92%), Divi's Laboratories (34.50%), Torrent Pharmaceuticals (37.68%). From a 5 year perspective, NGL Fine - Chem has underperformed peers relative to Sun Pharmaceutical Industries (19.84%) and Divi's Laboratories (10.95%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 3,256.53 | 3,328.4 |
| 10 | 3,243.01 | 3,280.69 |
| 20 | 3,190.73 | 3,218.39 |
| 50 | 3,022.35 | 3,025.19 |
| 100 | 2,649.43 | 2,733.24 |
| 200 | 2,134.71 | 2,350.95 |
Source: Dion Global
In the latest quarter, NGL Fine - Chem saw a drop in promoter holding to 72.50%, while DII stake increased to 0.02%, FII holding rose to 0.05%, and public shareholding moved up to 27.43% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Aug 07, 2026, 05:23 AM IST IST | NGL Fine-Chem - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of SEBI (Listing Obligations |
| Jul 31, 2026, 11:58 PM IST IST | NGL Fine-Chem - Business Responsibility and Sustainability Reporting (BRSR) |
| Jul 31, 2026, 11:54 PM IST IST | NGL Fine-Chem - Reg. 34 (1) Annual Report. |
| Jul 31, 2026, 11:44 PM IST IST | NGL Fine-Chem - Submission Of Notice Of 45Th Annual General Meeting And Annual Report For The Financial Year 2025-26 |
| Jul 13, 2026, 08:00 PM IST IST | NGL Fine-Chem - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Source: Dion Global
NGL Fine - Chem Ltd. is a Public Limited Listed company incorporated on 18/12/1981 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24110MH1981PLC025884 and registration number is 025884. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 488.77 Cr. and Equity Capital is Rs. 3.09 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for NGL Fine - Chem is ₹3,429.00 as on Aug 07, 2026.
The NGL Fine - Chem is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of NGL Fine - Chem is ₹2,118.44 Cr as on Aug 07, 2026.
Today’s highest and lowest price of NGL Fine - Chem are ₹3,442.65 and ₹3,333.00.
The 52-week high/low is the highest and lowest price at which NGL Fine - Chem stock has traded in the past 52-week or nearly a year. The 52-week high of NGL Fine - Chem is ₹3,536.00 and 52-week low of NGL Fine - Chem is ₹1,180.00 as on Aug 07, 2026.
The NGL Fine - Chem has shown returns of -0.18% over the past day, 10.91% for the past month, 28.86% over 3 months, 178.1% over 1 year, 16.09% across 3 years, and 0.67% over 5 years.
P/E ratio of and PB ratio of NGL Fine - Chem are 44.10 and 6.43 on Aug 07, 2026. While the company gives a dividend yield of 0.05 per annum.
Source: Dion Global